[1] |
Fan L, Strasser-Weippl K, Li JJ,et al. Breast cancer in China[J].Lancet Oncol,2014,15(7):e279-289.
|
[2] |
Piredda M,Biagioli V,Giannarelli D, et al. Improving cancer patients'knowledge about totally implantable access port: a randomized controlled trial[J].Support Care Cancer,2016,24(2):833-841.
|
[3] |
An H, Ryu CG, Jung EJ,et al. Insertion of totally implantable central venous access devices by surgeons[J]. Ann Coloproctol,2015,31(2):63-67.
|
[4] |
刘冰,尹杰.完全植入式静脉输液港手术方式及并发症研究进展[J/CD].中华临床医师杂志(电子版),2014,8(20):3704-3708.
|
[5] |
孙玉巧,周涛,李云涛.完全植入式静脉输液港的临床应用[J]. 中华外科杂志,2014,52(8):608-611.
|
[6] |
Akmangit I,Dede D,Daglioglu E,et al. A comparative study of lowprofile and regular type totally implantable venous access devices in patients with malignant tumors: retrospective analysis of 4501 implantations[J]. Int J Hematol Oncol,2014,24(2):97-105.
|
[7] |
李剑,杜端明,邱水波,等. 不同路径植入输液港的临床应用研究[J].中国基层医药,2015,22(10):1520-1523.
|
[8] |
Barbetakis N, Asteriou C, Kleontas A, et al. Totally implantable central venous access ports. analysis of 700 cases[J]. J Surg Oncol,2011,104(6):654-656.
|
[9] |
周媛,周倩.肿瘤患者植入式静脉输液港并发症及其护理对策[J].江苏医药,2015,41(5):613-614.
|
[10] |
Fankhauser GT,Fowl RJ,Stone WM,et al.Elimination of pneumothorax and hemothorax during placement of implantable venous access ports using ultrasound and fluoroscopiguidance[J]. Vascular,2013,21(6):345-348.
|
[11] |
Elsharkawy H, Lewis BS, Steiger E, et al. Post placement positional atrial fibrillation and peripherally inserted central catheters [J].Minerva Anestesiol,2009,75(7-8):471-474.
|
[12] |
刘艳萍,钱丰,谢潇,等.彩色多普勒超声实时引导经外周静脉穿刺植入中心静脉导管的实用价值[J].临床超声医学杂志,2012,14(3):195-197.
|
[13] |
Lebeaux D, Fernández-Hidalgo N, Chauhan A,et al. Management of infections related to totally implantable venous-access ports: challenges and perspectives[J]. Lancet Infect Dis,2014,14,(2):146-159.
|
[14] |
Wang TY, Lee KD, Chen PT,et al. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients[J].J Formos Med Assoc,2015,114(11):1055-1060.
|
[15] |
Wildgruber M,Lueg C,Borgmeyer S,et al.Polyurethane versus silicone catheters for central venous port devices implanted at the forearm[J].Eur J Cancer,2016,59:113-124.
|
[16] |
Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention,2009-2010[J]. Infect Control Hosp Epidemiol,2013,34(1):1-14.
|
[17] |
Vidal M, Genillon JP,Forestier E,et al.Outcome of totally implantable venous-access port-related infections [J]. Med Mal Infect, 2016,46(1):32-38.
|
[18] |
Bustos C, Aguinaga A, Carmona-Torre F, et al. Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections [J]. Infect Drug Resist,2014,7:25-35.
|
[19] |
Silva TN, Mendes ML, Abrão JM, et al. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin[J]. Int Urol Nephrol,2013,45(5):1405-1413.
|
[20] |
Wildgruber M,Borgmeyer S, Haller B,et al. Short-term and long-term outcome of radiological-guided insertion of central venous access port devices implanted at the forearm:a retrospective monocenter analysis in 1704 patients[J].Eur Radiol,2015,25(3):606-616.
|
[21] |
Boddi M, Villa G, Chiostri M,et al. Incidence of ultrasound-detected asymptomatic long-term central vein catheter-related thrombosis and fibrin sheath in cancer patients[J]. Eur J Haematol, 2015,95(5):472-479.
|
[22] |
Ma LI, Liu Y, Wang J,et al. Totally implantable venous access port systems and associated complications: a single-institution retrospective analysis of 2996 breast cancer patients[J]. Mol Clin Oncol,2016,4(3):456-460.
|
[23] |
李小庭,刘丁,王亚彬,等.早期应用尿激酶预防及治疗长期透析导管纤维蛋白鞘[J].南方医科大学学报,2014,34(11):1668-1671.
|
[24] |
Almasi-Sperling V, Hieber S, Lermann J,et al. Femoral placement of totally implantable venous access ports in patients with bilateral breast cancer[J].Geburtshilfe Frauenheilkd,2016,76(1):53-58.
|
[25] |
Fischer L, Knebel P, Schröder S,et al. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients[J]. Ann Surg Oncol,2008,15(4):1124-1129.
|
[26] |
Goltz JP,Schmid JS,Ritter CO,et al. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm[J]. J Vasc Access,2012,13(1):79-85.
|
[27] |
Goltz JP, Scholl A, Ritter CO, et al. Peripherally placed totally implantable venous-access port systems of the forearm: clinical experience in 763 consecutive patients [J]. Cardiovasc Intervent Radiol,2010,33(6):1159-1167.
|
[28] |
Gonda SJ, Li R. Principles of subcutaneous port placement[J]. Tech Vasc Interv Radiol,2011,14(4):198-203.
|
[29] |
Chang YF, Lo AC, Tsai CH, et al. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer— a single institution retrospective analysis[J]. Palliat Med,2013,27(2):185-191.
|
[30] |
徐波,耿翠芝.肿瘤治疗血管通道安全指南[M].北京:中国协和医科大学出版社,2015:143.
|
[31] |
Cho JB,Park IY,Sung KY,et al. Pinch-off syndrome[J].J Korean Surg Soc,2013,85(3):139-144.
|
[32] |
Viviani E, Giribono AM, Ferrara D, et al.Chest pain due to pinch-off syndrome: radiological findings and endovascular rescue[J].Clin Ter,2016,167(1):13-15.
|
[33] |
Le A, Patel S. Extravasation of noncytotoxic drugs: a review of the literature[J]. Ann Pharmacother,2014,48(7):870-886.
|
[34] |
Ben Kridis W, Sahnoun M, Maraoui H,et al. Fracture at catheter of totally implantable venous access port with migration into the right pulmonary artery: a serious complication[J].Acta Clin Belg,2016,13:1-4.
|
[35] |
胡飞翔,蔡明,淳林,等. 输液港在乳腺癌患者化疗中的临床应用[J/CD].中华乳腺病杂志(电子版),2014,8(1):59-61.
|
[36] |
Rouzrokh M, Shamsian BS, KhaleghNejad Tabari A, et al. Totally implantable subpectoral vs. subcutaneous port systems in children with malignant diseases[J]. Arch Iran Med,2009,12(4):389-394.
|
[37] |
Xiao SP, Xiong B, Chu J,et al.Fracture and migration of implantable venous access port catheters: cause analysis and management of 4 cases[J]. J Huazhong Univ Sci Technolog,2015,35(5):763-765.
|
[38] |
Cai Y, Li Y, Deng Y, et al.Upper arm vein versus subclavian vein for totally implantable venous access ports for patients with gastrointestinal malignancy: a retrospective comparison of complications[J]. Zhonghua Wei Chang Wai Ke Za Zhi,2015,18(10):1002-1005.蔡永华,黎燕红,叶俊文,等.上臂静脉与锁骨下静脉入路输液港应用于胃肠肿瘤化疗的并发症比较[J]. 中华胃肠外科杂志,2015,18(10):1002-1005.
|
[39] |
Mori Y, Nagayama S, Kawamura J,et al. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute[J].Int J Clin Oncol,2016,21(3):474-482.
|